11/11
11:18 am
ctso
Cytosorbents Co. (NASDAQ: CTSO) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
High
Report
Cytosorbents Co. (NASDAQ: CTSO) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.